Author:
Teti Claudia,Talco Miryam,Albertelli Manuela,Albanese Valeria,Minuto Michele,Aglialoro Alberto,Monachesi Mario,Viviani Giorgio,Gatto Federico,Ferone Diego,Boschetti Mara
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference5 articles.
1. Holst JJ (2006) Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005. Diabetologia 49:253–260
2. Wiedeman PE, Trevillyan JM (2003) Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes. Curr Opin Investig Drugs 4:412–420
3. Faidley TD, Leiting B, Pryor KD, Lyons K, Hickey GJ, Thompson R (2006) Inhibition of dipeptidyl-peptidase IV does not increase circulating IGF-I concentrations in growing pigs. Exper Biol Med (Maywood) 231:1373–1378
4. Frohman LA, Downs TR, Heimer EP, Felix AM (1989) Dipeptidyl peptidase IV and trypsin-like enzymatic degradation of human growth hormone releasing hormone in plasma. J Clin Invest 83:1533–1540
5. Mentlein R (1999) Dipeptidyl-peptidase IV (CD26) role in the inactivation of regulatory peptides. Reg Pept 85:9–24
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献